8.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$8.07
Aprire:
$8.14
Volume 24 ore:
7.14M
Relative Volume:
1.21
Capitalizzazione di mercato:
$2.13B
Reddito:
$6.28B
Utile/perdita netta:
$700.00M
Rapporto P/E:
3.0421
EPS:
2.6922
Flusso di cassa netto:
$537.00M
1 W Prestazione:
+14.23%
1M Prestazione:
+14.71%
6M Prestazione:
-15.74%
1 anno Prestazione:
-47.90%
Organon Co Stock (OGN) Company Profile
Nome
Organon Co
Settore
Industria
Telefono
551-430-6000
Indirizzo
30 HUDSON STREET, JERSEY CITY
Confronta OGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OGN
Organon Co
|
8.19 | 2.10B | 6.28B | 700.00M | 537.00M | 2.6922 |
|
LLY
Lilly Eli Co
|
1,108.09 | 952.34B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.49 | 493.40B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
233.42 | 395.77B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
141.98 | 272.99B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
108.60 | 270.22B | 63.90B | 19.05B | 13.05B | 7.5596 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-10-27 | Downgrade | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-09-06 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Downgrade | Goldman | Buy → Neutral |
| 2023-09-21 | Iniziato | Barclays | Overweight |
| 2023-03-16 | Iniziato | Raymond James | Outperform |
| 2022-10-14 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Iniziato | Piper Sandler | Neutral |
| 2021-09-01 | Iniziato | BofA Securities | Buy |
| 2021-07-22 | Iniziato | Citigroup | Buy |
| 2021-06-15 | Iniziato | JP Morgan | Neutral |
| 2021-06-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Organon Co Borsa (OGN) Ultime notizie
Organon Named Top Dividend Stock With Insider Buying and 0.99% Yield (OGN) - Nasdaq
Organon & Co. (OGN) Stock Analysis: Exploring The 25.77% Potential Upside For Investors - DirectorsTalk Interviews
Is Organon (NYSE:OGN) A Risky Investment? - 富途牛牛
Organon & Co. Sees Unusually Large Options Volume (NYSE:OGN) - MarketBeat
Great week for Organon & Co. (NYSE:OGN) institutional investors after losing 51% over the previous year - simplywall.st
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Samsung Bioepis Denies Organon Deal Rumors - Citeline News & Insights
Samsung Bioepis pursues direct sales by weighing Organon acquisition to boost profitsCHOSUNBIZ - Chosunbiz
Samsung Bioepis reviews Organon acquisition to boost direct biosimilar salesCHOSUNBIZ - Chosunbiz
Mixed Martial Arts Group Limited Stock Analysis and ForecastTechnical Resistance Breaks & Stay One Step Ahead of Risk Events - earlytimes.in
Organon & Co. (NYSE:OGN) Upgraded at Wall Street Zen - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
Understanding the Setup: (OGN) and Scalable Risk - Stock Traders Daily
Will Organon Co 7XP stock outperform value peersMarket Growth Report & Fast Exit and Entry Trade Guides - moha.gov.vn
Volume Summary: How Organon Co stock reacts to inflationary pressuresBreakout Watch & Expert-Curated Trade Recommendations - moha.gov.vn
Does Organon’s 50% Share Price Slide Signal Opportunity in 2025? - Yahoo Finance
Gilman Hill Asset Management LLC Reduces Position in Organon & Co. $OGN - MarketBeat
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - sharewise.com
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know - sharewise.com
Why (OGN) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Organon: Deep Value With No Clear Catalysts (NYSE:OGN) - Seeking Alpha
Pharma co Organon inks VPPA with Schneider Electric for solar in Spain - Renewables Now
Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - TMX Newsfile
Organon & Co. (NYSE:OGN) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Organon pushes for sustainable investment in women’s health across Africa - The Business & Financial Times
TetraScience and Organon Collaborate to Modernize Quality Control Data Management - 富途牛牛
3 Healthcare Stocks with Questionable Fundamentals - The Globe and Mail
Organon Launches Phase 3 Study on Tapinarof Cream for Atopic Dermatitis in Infants - TipRanks
How Investors Are Reacting To Organon (OGN) As Barclays Joins Growing Analyst Skepticism - Sahm
Why Analysts See Organon’s Story Shifting Amid Governance Concerns And Lower Valuations - Yahoo Finance
Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance
Organon & Co. $OGN Stake Lessened by Globeflex Capital L P - MarketBeat
Organon Shares Under Pressure Following Critical Analyst Review - AD HOC NEWS
Can Organon’s Steep 2025 Share Price Slide Signal a Long Term Opportunity? - simplywall.st
Organon pushes bold women’s health agenda at WHX Leaders’ Summit in Accra - MyJoyOnline
Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes - GlobeNewswire Inc.
Why Organon (OGN) shares are trading lower today - MSN
New York State Common Retirement Fund Sells 353,330 Shares of Organon & Co. $OGN - MarketBeat
Understanding Momentum Shifts in (OGN) - news.stocktradersdaily.com
Investors in Organon & Co. (OGN): Protect Your RightsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
Organon & Co. (NYSE:OGN) Stock Rating Upgraded by Barclays - MarketBeat
Organon & Co. $OGN Shares Bought by Cerity Partners LLC - MarketBeat
WHX Africa Leaders Summit: Organon Unveils Multi-Sector Approach to Women’s Health in Africa - News Ghana
Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq
Why Organon (OGN) Shares Are Trading Lower Today - Finviz
Organon (OGN) Receives New Coverage with 'Underweight' Rating fr - GuruFocus
Barclays Initiates Coverage on Organon & Co. (NYSE:OGN) - MarketBeat
Norges Bank Takes $19.78 Million Position in Organon & Co. $OGN - MarketBeat
Organon initiated with an Underweight at Barclays - TipRanks
American Century Companies Inc. Grows Position in Organon & Co. $OGN - MarketBeat
Organon Co Azioni (OGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):